deltatrials
Completed NA NCT00373048

Mefloquine Prophylaxis in HIV-1 Individuals: a Randomized Placebo-controlled Trial

Mefloquine Malaria Prophylaxis in HIV-1 Infected Individuals and Its Influence on the Evolution Towards AIDS: a Randomized Placebo-controlled Trial

Sponsor: Institute of Tropical Medicine, Belgium

Conditions HIV Infections
Interventions mefloquine placebo
Updated 5 times since 2017 Last updated: May 23, 2011 Started: Oct 31, 2005 Primary completion: Dec 31, 2007 Completion: May 31, 2011

A NA clinical study on HIV Infections, this trial is completed. The trial is conducted by Institute of Tropical Medicine, Belgium and has accumulated 5 data snapshots since 2005. Infectious disease trials contribute critical data for public health response and treatment development.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Jan 2021 — Jul 2024 [monthly]

    Completed NA

  4. Jun 2018 — Jan 2021 [monthly]

    Completed NA

  5. Jan 2017 — Jun 2018 [monthly]

    Completed NA

    First recorded

Oct 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Institute of Tropical Medicine, Belgium
Data source: Institute of Tropical Medicine, Belgium

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Ndola, Zambia